Fundamentals and stats
ABIONYX Pharma SA financial statements, including revenue, expenses, and profit
The total revenue of ABNX for the last semiannual is 2.12 M EUR, and it's 3.99% lower compared to the previous semiannual. The net income of H1 25 is -2.31 M EUR.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM